Cargando…

Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes

The major histocompatibility complex class Ib protein, Qa-1(b), serves as a ligand for murine CD94/NKG2A natural killer (NK) cell inhibitory receptors. The Qa-1(b) peptide-binding site is predominantly occupied by a single nonameric peptide, Qa-1 determinant modifier (Qdm), derived from the leader s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraft, Jennifer R., Vance, Russell E., Pohl, Jan, Martin, Amy M., Raulet, David H., Jensen, Peter E.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193274/
https://www.ncbi.nlm.nih.gov/pubmed/10974028
_version_ 1782147432175370240
author Kraft, Jennifer R.
Vance, Russell E.
Pohl, Jan
Martin, Amy M.
Raulet, David H.
Jensen, Peter E.
author_facet Kraft, Jennifer R.
Vance, Russell E.
Pohl, Jan
Martin, Amy M.
Raulet, David H.
Jensen, Peter E.
author_sort Kraft, Jennifer R.
collection PubMed
description The major histocompatibility complex class Ib protein, Qa-1(b), serves as a ligand for murine CD94/NKG2A natural killer (NK) cell inhibitory receptors. The Qa-1(b) peptide-binding site is predominantly occupied by a single nonameric peptide, Qa-1 determinant modifier (Qdm), derived from the leader sequence of H-2D and L molecules. Five anchor residues were identified in this study by measuring the peptide-binding affinities of substituted Qdm peptides in experiments with purified recombinant Qa-1(b). A candidate peptide-binding motif was determined by sequence analysis of peptides eluted from Qa-1 that had been folded in the presence of random peptide libraries or pools of Qdm derivatives randomized at specific anchor positions. The results indicate that Qa-1(b) can bind a diverse repertoire of peptides but that Qdm has an optimal primary structure for binding Qa-1(b). Flow cytometry experiments with Qa-1(b) tetramers and NK target cell lysis assays demonstrated that CD94/NKG2A discriminates between Qa-1(b) complexes containing peptides with substitutions at nonanchor positions P4, P5, or P8. Our findings suggest that it may be difficult for viruses to generate decoy peptides that mimic Qdm and raise the possibility that competitive replacement of Qdm with other peptides may provide a novel mechanism for activation of NK cells.
format Text
id pubmed-2193274
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21932742008-04-16 Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes Kraft, Jennifer R. Vance, Russell E. Pohl, Jan Martin, Amy M. Raulet, David H. Jensen, Peter E. J Exp Med Original Article The major histocompatibility complex class Ib protein, Qa-1(b), serves as a ligand for murine CD94/NKG2A natural killer (NK) cell inhibitory receptors. The Qa-1(b) peptide-binding site is predominantly occupied by a single nonameric peptide, Qa-1 determinant modifier (Qdm), derived from the leader sequence of H-2D and L molecules. Five anchor residues were identified in this study by measuring the peptide-binding affinities of substituted Qdm peptides in experiments with purified recombinant Qa-1(b). A candidate peptide-binding motif was determined by sequence analysis of peptides eluted from Qa-1 that had been folded in the presence of random peptide libraries or pools of Qdm derivatives randomized at specific anchor positions. The results indicate that Qa-1(b) can bind a diverse repertoire of peptides but that Qdm has an optimal primary structure for binding Qa-1(b). Flow cytometry experiments with Qa-1(b) tetramers and NK target cell lysis assays demonstrated that CD94/NKG2A discriminates between Qa-1(b) complexes containing peptides with substitutions at nonanchor positions P4, P5, or P8. Our findings suggest that it may be difficult for viruses to generate decoy peptides that mimic Qdm and raise the possibility that competitive replacement of Qdm with other peptides may provide a novel mechanism for activation of NK cells. The Rockefeller University Press 2000-09-05 /pmc/articles/PMC2193274/ /pubmed/10974028 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Original Article
Kraft, Jennifer R.
Vance, Russell E.
Pohl, Jan
Martin, Amy M.
Raulet, David H.
Jensen, Peter E.
Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes
title Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes
title_full Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes
title_fullStr Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes
title_full_unstemmed Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes
title_short Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes
title_sort analysis of qa-1(b)peptide binding specificity and the capacity of cd94/nkg2a to discriminate between qa-1–peptide complexes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193274/
https://www.ncbi.nlm.nih.gov/pubmed/10974028
work_keys_str_mv AT kraftjenniferr analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes
AT vancerusselle analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes
AT pohljan analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes
AT martinamym analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes
AT rauletdavidh analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes
AT jensenpetere analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes